Parental Attitudes toward Ethical and Social Issues Surrounding the Expansion of Newborn Screening Using New Technologies

被引:47
作者
Hasegawa, L. E. [1 ]
Fergus, K. A. [1 ]
Ojeda, N. [2 ]
Au, S. M. [1 ]
机构
[1] Hawaii Dept Hlth, Children Special Needs Branch, Hawaii Genet Program, Honolulu, HI 96816 USA
[2] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA USA
关键词
Cultural differences; Ethical issues; Focus group; Informed consent; Metabolic disorders; Newborn screening; Qualitative analysis; Social issues; ADULT-ONSET DISEASES; INFORMED-CONSENT; PRENATAL-CARE; CHILDREN; RECOMMENDATIONS; PROVIDERS; COMMUNICATION; INFORMATION; PEDIATRICS; OPINIONS;
D O I
10.1159/000314644
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aims: This study assessed parent knowledge of newborn screening (NBS) and parent attitudes toward NBS for untreatable conditions, NBS for late-onset disorders and informed consent in NBS. Methods: Seventeen qualitative focus groups were held in Alaska, California, Hawaii, and Washington with mothers of children 10 years old or younger. Results: Most participants did not recall receiving information about NBS, and all wanted this information prenatally. In addition, most felt that the current system of 'informed dissent' was adequate, provided they were told about NBS prior to delivery. All women supported NBS for conditions that occur in infancy without a proven treatment. However, they disagreed about NBS for disorders that manifest in late childhood or adulthood. Conclusions: The results show a general consensus among the focus group participants about issues that cause dissent among public health and health care professionals. Parent attitudes differ from those of many professional communities with regard to timing of NBS education, informed consent, NBS for disorders that lack an effective treatment, and predictive testing of children for late-onset disorders. The results highlight the need to further research parent opinions about expanded NBS using new technologies and to include parents in the development of NBS policies. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:298 / 306
页数:9
相关论文
共 49 条
[1]  
*ACOG COMM GEN, 2003, OBSTET GYNECOL, V102, P887
[2]   A vision of the future of newborn screening [J].
Alexander, D ;
van Dyck, PC .
PEDIATRICS, 2006, 117 (05) :S350-S354
[3]  
*AM AC PED NEWB SC, 2000, PEDIATRICS, V106, pS389
[4]  
[Anonymous], 1968, PUBLIC HLTH PAP, DOI DOI 10.1001/ARCHINTE.1969.00300130131020
[5]  
ASHG ACMG, 1995, AM J HUM GENET, V57, P1233
[6]   New born screening for developmental disabilities: Reframing presumptive benefit [J].
Bailey, DB ;
Skinner, D ;
Warren, SF .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (11) :1889-1893
[7]  
Bailey Donald B Jr, 2009, Health Matrix Clevel, V19, P141
[8]  
Baily MA, 2008, HASTINGS CENT REP, V38, P23
[9]   Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics Recommendations of the European Society of Human Genetics [J].
Borry, Pascal ;
Evers-Kiebooms, Gerry ;
Cornel, Martina C. ;
Clarke, Angus ;
Dierickx, Kris .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (06) :720-721
[10]   Newborn screening technology: Proceed with caution [J].
Botkin, JR ;
Clayton, EW ;
Fost, NC ;
Burke, W ;
Murray, TH ;
Baily, MA ;
Wilfond, B ;
Berg, A ;
Ross, LF .
PEDIATRICS, 2006, 117 (05) :1793-1799